Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Page

Showing results (191-200 of 222) with videos related to

Pageof 23
Sort By:
Journal of Addiction Medicine|October 30, 2024
Current Self-reported Pain Before and After Cure of Hepatitis C Among Persons Who Actively Inject DrugsJudith I Tsui, Natasha T Ludwig-Barron, Jocelyn R James, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2019
Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C InfectionLouise Geddes, Jenny Iversen, Handan Wand, et al.
JAMA Internal Medicine|April 7, 2025
Hospital Addiction Consultation Service and Opioid Use Disorder Treatment: The START Randomized Clinical TrialAllison J Ober, Cristina Murray-Krezan, Kimberly Page, et al.
Viruses|October 26, 2024
Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO StudySnehal S Lopes, Moonseong Heo, Irene Pericot-Valverde, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
The Effect of Female Sex on Hepatitis C Incidence Among People Who Inject Drugs: Results From the International Multicohort InC3 CollaborativeAryan Esmaeili, Ali Mirzazadeh, Meghan D Morris, et al.
Immunogenetics|September 8, 2011
KIR genotypic diversity can track ancestries in heterogeneous populations: a potential confounder for disease association studiesKomal Manpreet Singh, Yume T Phung, Mohamed S Kohla, et al.
The International Journal on Drug Policy|December 16, 2023
Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO studySnehal S Lopes, Irene Pericot-Valverde, Julia Arnsten, et al.
BMC Infectious Diseases|February 23, 2024
Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO studySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
Drug and Alcohol Dependence|May 7, 2023
Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugsJudith I Tsui, Paula J Lum, Lynn E Taylor, et al.
Open Forum Infectious Diseases|November 29, 2023
Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO StudyIrene Pericot-Valverde, Snehal S Lopes, Shadi Nahvi, et al.
Pageof 23

Showing results (191-200 of 222) with videos related to

Sort By:
Pageof 23
Journal of Addiction Medicine|October 30, 2024
Current Self-reported Pain Before and After Cure of Hepatitis C Among Persons Who Actively Inject DrugsJudith I Tsui, Natasha T Ludwig-Barron, Jocelyn R James, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2019
Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C InfectionLouise Geddes, Jenny Iversen, Handan Wand, et al.
JAMA Internal Medicine|April 7, 2025
Hospital Addiction Consultation Service and Opioid Use Disorder Treatment: The START Randomized Clinical TrialAllison J Ober, Cristina Murray-Krezan, Kimberly Page, et al.
Viruses|October 26, 2024
Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO StudySnehal S Lopes, Moonseong Heo, Irene Pericot-Valverde, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
The Effect of Female Sex on Hepatitis C Incidence Among People Who Inject Drugs: Results From the International Multicohort InC3 CollaborativeAryan Esmaeili, Ali Mirzazadeh, Meghan D Morris, et al.
Immunogenetics|September 8, 2011
KIR genotypic diversity can track ancestries in heterogeneous populations: a potential confounder for disease association studiesKomal Manpreet Singh, Yume T Phung, Mohamed S Kohla, et al.
The International Journal on Drug Policy|December 16, 2023
Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO studySnehal S Lopes, Irene Pericot-Valverde, Julia Arnsten, et al.
BMC Infectious Diseases|February 23, 2024
Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO studySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
Drug and Alcohol Dependence|May 7, 2023
Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugsJudith I Tsui, Paula J Lum, Lynn E Taylor, et al.
Open Forum Infectious Diseases|November 29, 2023
Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO StudyIrene Pericot-Valverde, Snehal S Lopes, Shadi Nahvi, et al.
Pageof 23